PerkinElmer Inc Stock News

The laboratory testing company saw its shares plummet nearly $40 per share over the course of the month.

The laboratory testing company saw its shares plummet nearly $40 per share over the course of the month.

PerkinElmer's (PKI) fourth-quarter results benefit from solid performance at Discover & Analytics Solutions business.

PerkinElmer's (PKI) fourth-quarter results benefit from solid performance at Discover & Analytics Solutions business.

PerkinElmer Inc's  PKI Q4 revenues increased 1% Y/Y (down 9% organically) to $1.36 billion, beating the consensus of $1.29 billion. In January, the Company anticipated reported and organic revenue g

PerkinElmer (PKI) delivered earnings and revenue surprises of 19.07% and 9.46%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

PerkinElmer's (PKI) CEO Prahlad Singh on Q4 2021 Results - Earnings Call Transcript

PerkinElmer (PKI) delivered earnings and revenue surprises of 19.07% and 9.46%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

PerkinElmer (NYSE:PKI) is scheduled to announce Q4 earnings results on Tuesday, February 1st, after market close.The consensus EPS Estimate is $2.38 (-39.9% Y/Y) and the consensus

PerkinElmer (PKI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

PerkinElmer (PKI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

PerkinElmer (PKI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PerkinElmer's (PKI) fourth-quarter results are likely to reflect strong performance at the Diagnostics segment.

PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.